- Oocyte donation to women of advanced reproductive age is similar to donation to younger recipients, although precycle screening is more extensive.
- Although the incidence of gestational diabetes and preeclampsia appears to be increased in women over 40, neonatal outcomes are roughly equivalent to those of younger women.
- Relatively few women over 50 seek ART; to date, fewer than 300 pregnancies have been reported in this age group worldwide.
The age-related decline in human fertility is a well-documented phenomenon. Studies in natural populations have clearly shown that as women get older, birth rates decrease—an effect that first becomes apparent at approximately 30 years of age.1
In the United States, babies born to women over the age of 40 represent less than 1% of total live births.2 By age 47, this number decreases to a mere 0.01%.3 Although it is unclear whether these low rates are due to age-related physiologic changes or merely reflect alterations in behavior, evidence suggests that a real decline in fertility accompanies female aging.4,5 This decline parallels an increase in chromosomal anomalies observed in the oocytes and embryos of older women.6,7 What remains to be determined is whether these abnormalities reflect an inherent deficiency of the remaining oocytes within the ovary, or whether the aging cytoplasm promotes the development of aneuploidy during meiosis or subsequent mitotic divisions.8,9
Neither simple nor complex fertility treatments have been able to overcome the age-related decline in fertility. Statistics generated by the Society for Assisted Reproductive Technology (SART) Registry have consistently demonstrated a live birth rate of less than 10% per embryo transfer in women over the age of 40. Other studies of embryo transfer using autologous oocytes have yielded similar findings in this age group.10-12
The age of the egg donor
Older women who receive donor oocytes demonstrate implantation and pregnancy rates that are essentially the same as those of younger women.13 Thus, the success of assisted reproductive technology seems dependent on the age of the donor, rather than the recipient.14
Although it may seem obvious now, the fact that female reproductive aging is concentrated in the oocyte was not known before oocyte donation became a common practice—nor was it necessarily anticipated. The clinical practice of oocyte donation evolved as a natural consequence of standard in vitro fertilization embryo transfer (IVF-ET). Since the gametes were collected independently and then combined in the laboratory, oocyte donation was conceptually no different from sperm donation. The key distinction was the difficulty of retrieving donated oocytes.
Initially, the problem was solved using a method known as “ovum donation,” in which the donor was inseminated with the sperm of the infertile woman’s partner. The oocyte was fertilized in vivo, then retrieved from the uterus using a flushing method. This process was relatively simple and required no anesthesia or operating room. The first pregnancy achieved in this manner was reported in 1983.15
Unfortunately, there were problems with this approach, among them the risk of sexually transmitted disease (STD) and the potential for a retained pregnancy in the donor.16 But the biggest drawback was the lack of efficiency: A viable embryo was recovered in only a small proportion of natural cycles, and attempts at superovulation were unsuccessful.16
Still, as technology advanced, success rates improved. Even though laparoscopy was still needed for oocyte retrieval, the practice of egg donation shifted toward standard IVF methodology, with fertilization performed in vitro rather than in vivo. Trounson et al were the first to report a successful pregnancy using this method.17 Shortly thereafter, Lutjen et al reported a pregnancy in an agonadal recipient.18 Oocyte donation had become a standard part of the ART armamentarium.
A high success rate
The technological advance that played the greatest role in further accelerating the refinement of oocyte donation was transvaginal follicle aspiration. Laparoscopy was no longer needed, and oocyte retrieval became an outpatient procedure that did not require anesthesia. As a result, donors could be recruited with greater ease. As the relatively high degree of success of oocyte donation became apparent,19 direct comparisons of it and standard IVF became possible.20 These comparisons clearly demonstrated that endometrial receptivity and oocyte quality are 2 separate entities, each of which can affect overall success.21
The high success rates associated with oocyte donation in younger women were mirrored in those over 40.
Prior to 1990, no series had explored oocyte donation to women of advanced reproductive age. This process was considered a therapy for young women with premature ovarian failure rather than a means of overcoming the age-related decline in fertility. Thus, it was serendipitous to discover that the high success rates associated with oocyte donation in younger women were mirrored in those over 4022 and that the age of the uterus does not appear to play a significant role. After a number of reports confirmed the efficacy of oocyte donation in older women,23-25 pregnancies were achieved even in women over 50.26,27